ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,062Medicare Part D Prescriptions Filled, Including Refills

Rank: 211 out of 939

$456K Total Retail Price of All Prescriptions

Rank: 296 out of 939

473 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 473 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 473 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 8,759 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
SIMVASTATIN 619 526 1 2
LISINOPRIL 525 457 2 3
HYDROCODONE-ACETAMINOPHEN 399 273 S3 3 1
METFORMIN HCL 375 311 4 8
LEVOTHYROXINE SODIUM 346 312 5 4
ATENOLOL 317 248 6 19
OMEPRAZOLE 316 204 7 5
FUROSEMIDE 267 238 8 7
POTASSIUM CHLORIDE 240 201 9 9
TRAMADOL HCL 215 143 10 16
AMLODIPINE BESYLATE 185 135 11 6
ALENDRONATE SODIUM 177 163 12 40
CARVEDILOL 171 166 13 25
ATORVASTATIN CALCIUM 166 148 14 22
PRAVASTATIN SODIUM 158 140 15 13
CITALOPRAM HBR 140 132 16 15
METOPROLOL SUCCINATE 139 120 17 21
ALLOPURINOL 134 129 18 31
LISINOPRIL-HYDROCHLOROTHIAZIDE 129 108 19 23
SERTRALINE HCL 128 70 20 24
GABAPENTIN 126 105 21 11
FAMOTIDINE 126 92 21 62
GLIMEPIRIDE 118 89 23 37
DIGOXIN 116 116 24 45
HYDROCHLOROTHIAZIDE 114 75 25 12
WARFARIN SODIUM 112 103 26 17
TRAZODONE HCL 105 82 27 26
METOPROLOL TARTRATE 101 91 28 10
ACTOS 96 75 29 141
CRESTOR 95 68 30 34
TAMSULOSIN HCL 88 71 31 27
CLONIDINE HCL 88 51 31 39
CEPHALEXIN 86 62 33 77
OXYCODONE-ACETAMINOPHEN 83 60 S2 34 138
AMITRIPTYLINE HCL 82 69 R 35 38
EVISTA 79 67 36 122
NEXIUM 75 52 37 18
PROAIR HFA 73 40 38 41
CLOPIDOGREL 72 61 39 28
GLYBURIDE 71 65 R 40 89
ZOLPIDEM TARTRATE 67 43 41 20
FLUTICASONE PROPIONATE 65 52 42 43
AZITHROMYCIN 63 36 43 32
PAROXETINE HCL 60 56 44 70
NAMENDA 58 58 45 49
CALCITONIN-SALMON 57 56 46 289
LOVASTATIN 55 51 47 46
SPIRIVA 54 39 48 73
DIPHENOXYLATE-ATROPINE 54 50 48 300
METOCLOPRAMIDE HCL 54 54 48 119
FLUOXETINE HCL 53 49 51 47
CYCLOBENZAPRINE HCL 53 21 R 51 36
RISPERIDONE 52 45 53 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.